• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期非小细胞肺癌患者总生存期的预后模型:一项多中心回顾性研究。

A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.

机构信息

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.

Department of Biomedical Informatics, Stony Brook University, New York.

出版信息

Lancet Digit Health. 2020 Nov;2(11):e594-e606. doi: 10.1016/s2589-7500(20)30225-9. Epub 2020 Oct 19.

DOI:10.1016/s2589-7500(20)30225-9
PMID:33163952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7646741/
Abstract

BACKGROUND

Intratumoural heterogeneity has been previously shown to be related to clonal evolution and genetic instability and associated with tumour progression. Phenotypically, it is reflected in the diversity of appearance and morphology within cell populations. Computer-extracted features relating to tumour cellular diversity on routine tissue images might correlate with outcome. This study investigated the prognostic ability of computer-extracted features of tumour cellular diversity (CellDiv) from haematoxylin and eosin (H&E)-stained histology images of non-small cell lung carcinomas (NSCLCs).

METHODS

In this multicentre, retrospective study, we included 1057 patients with early-stage NSCLC with corresponding diagnostic histology slides and overall survival information from four different centres. CellDiv features quantifying local cellular morphological diversity from H&E-stained histology images were extracted from the tumour epithelium region. A Cox proportional hazards model based on CellDiv was used to construct risk scores for lung adenocarcinoma (LUAD; 270 patients) and lung squamous cell carcinoma (LUSC; 216 patients) separately using data from two of the cohorts, and was validated in the two remaining independent cohorts (comprising 236 patients with LUAD and 335 patients with LUSC). We used multivariable Cox regression analysis to examine the predictive ability of CellDiv features for 5-year overall survival, controlling for the effects of clinical and pathological parameters. We did a gene set enrichment and Gene Ontology analysis on 405 patients to identify associations with differentially expressed biological pathways implicated in lung cancer pathogenesis.

FINDINGS

For prognosis of patients with early-stage LUSC, the CellDiv LUSC model included 11 discriminative CellDiv features, whereas for patients with early-stage LUAD, the model included 23 features. In the independent validation cohorts, patients predicted to be at a higher risk by the univariable CellDiv model had significantly worse 5-year overall survival (hazard ratio 1·48 [95% CI 1·06-2·08]; p=0·022 for The Cancer Genome Atlas [TCGA] LUSC group, 2·24 [1·04-4·80]; p=0·039 for the University of Bern LUSC group, and 1·62 [1·15-2·30]; p=0·0058 for the TCGA LUAD group). The identified CellDiv features were also found to be strongly associated with apoptotic signalling and cell differentiation pathways.

INTERPRETATION

CellDiv features were strongly prognostic of 5-year overall survival in patients with early-stage NSCLC and also associated with apoptotic signalling and cell differentiation pathways. The CellDiv-based risk stratification model could potentially help to determine which patients with early-stage NSCLC might receive added benefit from adjuvant therapy.

FUNDING

National Institue of Health and US Department of Defense.

摘要

背景

肿瘤内异质性先前已被证明与克隆进化和遗传不稳定性有关,并与肿瘤进展相关。表型上,它反映在细胞群体中外观和形态的多样性上。计算机提取的与肿瘤细胞多样性相关的特征(CellDiv)可能与常规组织图像的肿瘤细胞多样性相关。本研究调查了从非小细胞肺癌(NSCLC)的苏木精和伊红(H&E)染色组织学图像中提取的计算机提取的肿瘤细胞多样性(CellDiv)特征对预后的影响。

方法

在这项多中心回顾性研究中,我们纳入了来自四个中心的 1057 名早期 NSCLC 患者的相应诊断组织学切片和总生存信息。从 H&E 染色组织学图像的肿瘤上皮区域提取量化局部细胞形态多样性的 CellDiv 特征。使用来自两个队列的数据,使用 Cox 比例风险模型基于 CellDiv 分别为肺腺癌(LUAD;270 例)和肺鳞状细胞癌(LUSC;216 例)构建风险评分,并在另外两个独立的队列中进行验证(包含 236 例 LUAD 患者和 335 例 LUSC 患者)。我们使用多变量 Cox 回归分析,控制临床和病理参数的影响,检查 CellDiv 特征对 5 年总生存率的预测能力。我们对 405 名患者进行了基因集富集和基因本体论分析,以确定与肺癌发病机制中涉及的差异表达生物途径的关联。

结果

对于早期 LUSC 患者的预后,CellDiv LUSC 模型包含 11 个有区别的 CellDiv 特征,而对于早期 LUAD 患者,该模型包含 23 个特征。在独立验证队列中,根据单变量 CellDiv 模型预测为高风险的患者,5 年总生存率显著降低(风险比 1.48[95%CI 1.06-2.08];p=0.022 用于癌症基因组图谱[TCGA]LUSC 组,2.24[1.04-4.80];p=0.039 用于伯尔尼大学 LUSC 组,1.62[1.15-2.30];p=0.0058 用于 TCGA LUAD 组)。还发现鉴定的 CellDiv 特征与凋亡信号和细胞分化途径密切相关。

解释

CellDiv 特征强烈预测了早期 NSCLC 患者 5 年的总生存率,并且还与凋亡信号和细胞分化途径有关。基于 CellDiv 的风险分层模型可能有助于确定哪些早期 NSCLC 患者可能从辅助治疗中获益。

资金来源

美国国立卫生研究院和美国国防部。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/ea4d543c0255/nihms-1639299-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/24d5079748b2/nihms-1639299-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/b144df8f82b9/nihms-1639299-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/8a919600d424/nihms-1639299-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/ea4d543c0255/nihms-1639299-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/24d5079748b2/nihms-1639299-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/b144df8f82b9/nihms-1639299-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/8a919600d424/nihms-1639299-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39c/7646741/ea4d543c0255/nihms-1639299-f0004.jpg

相似文献

1
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.早期非小细胞肺癌患者总生存期的预后模型:一项多中心回顾性研究。
Lancet Digit Health. 2020 Nov;2(11):e594-e606. doi: 10.1016/s2589-7500(20)30225-9. Epub 2020 Oct 19.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.西妥昔单抗联合化疗与单纯化疗用于初治晚期非小细胞肺癌的疗效比较
Cochrane Database Syst Rev. 2014 Nov 17;2014(11):CD009948. doi: 10.1002/14651858.CD009948.pub2.
7
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.用于经手术或根治性放疗治疗的Ⅰ至Ⅲ期非小细胞肺癌的免疫疗法(不包括检查点抑制剂)。
Cochrane Database Syst Rev. 2017 Dec 16;12(12):CD011300. doi: 10.1002/14651858.CD011300.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

引用本文的文献

1
HistoChat: Instruction-tuning multimodal vision language assistant for colorectal histopathology on limited data.HistoChat:用于有限数据上的结直肠癌组织病理学的指令微调多模态视觉语言助手。
Patterns (N Y). 2025 May 30;6(8):101284. doi: 10.1016/j.patter.2025.101284. eCollection 2025 Aug 8.
2
Progress and challenges of artificial intelligence in lung cancer clinical translation.人工智能在肺癌临床转化中的进展与挑战
NPJ Precis Oncol. 2025 Jul 1;9(1):210. doi: 10.1038/s41698-025-00986-7.
3
Computationally integrating radiology and pathology image features for predicting treatment benefit and outcome in lung cancer.

本文引用的文献

1
Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer.自噬相关基因特征在非小细胞肺癌中的预后意义
Aging (Albany NY). 2019 Dec 7;11(23):11440-11462. doi: 10.18632/aging.102544.
2
Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer.生物信息学分析揭示了6种与非小细胞肺癌相关的关键生物标志物。
J Int Med Res. 2020 Mar;48(3):300060519887637. doi: 10.1177/0300060519887637. Epub 2019 Nov 28.
3
Identification of seven-gene signature for prediction of lung squamous cell carcinoma.
通过计算整合放射学和病理学图像特征以预测肺癌的治疗获益和预后
NPJ Precis Oncol. 2025 Jun 4;9(1):161. doi: 10.1038/s41698-025-00939-0.
4
Deep learning informed multimodal fusion of radiology and pathology to predict outcomes in HPV-associated oropharyngeal squamous cell carcinoma.深度学习助力放射学与病理学的多模态融合,以预测人乳头瘤病毒相关口咽鳞状细胞癌的预后。
EBioMedicine. 2025 Apr;114:105663. doi: 10.1016/j.ebiom.2025.105663. Epub 2025 Mar 22.
5
The impact of combining cetuximab with the traditional chemotherapy regimens on clinical effectiveness in metastatic colorectal cancer: a systematic review and meta-analysis.西妥昔单抗联合传统化疗方案对转移性结直肠癌临床疗效的影响:一项系统评价和荟萃分析。
BMC Cancer. 2025 Feb 24;25(1):331. doi: 10.1186/s12885-025-13515-3.
6
Artificial intelligence in digital pathology - time for a reality check.数字病理学中的人工智能——是时候进行现实核查了。
Nat Rev Clin Oncol. 2025 Apr;22(4):283-291. doi: 10.1038/s41571-025-00991-6. Epub 2025 Feb 11.
7
AI-based tumor-infiltrating lymphocyte scoring system for assessing HCC prognosis in patients undergoing liver resection.基于人工智能的肿瘤浸润淋巴细胞评分系统用于评估肝切除患者的肝癌预后
JHEP Rep. 2024 Nov 12;7(2):101270. doi: 10.1016/j.jhepr.2024.101270. eCollection 2025 Feb.
8
Comprehensive analysis of the pituitary tumor-transforming gene (PTTG) family in lung adenocarcinoma: diagnostic, prognostic, and therapeutic implications.肺腺癌中垂体肿瘤转化基因(PTTG)家族的综合分析:诊断、预后及治疗意义
Am J Transl Res. 2024 Nov 15;16(11):6326-6345. doi: 10.62347/TSJB6900. eCollection 2024.
9
BEEx Is an Open-Source Tool That Evaluates Batch Effects in Medical Images to Enable Multicenter Studies.BEEx是一个开源工具,用于评估医学图像中的批次效应,以支持多中心研究。
Cancer Res. 2025 Jan 15;85(2):218-230. doi: 10.1158/0008-5472.CAN-23-3846.
10
A comprehensive nomogram for assessing the prognosis of non-small cell lung cancer patients receiving immunotherapy: a prospective cohort study in China.评估接受免疫治疗的非小细胞肺癌患者预后的综合列线图:一项在中国进行的前瞻性队列研究。
Front Immunol. 2024 Nov 20;15:1487078. doi: 10.3389/fimmu.2024.1487078. eCollection 2024.
用于预测肺鳞状细胞癌的七基因特征识别。
Onco Targets Ther. 2019 Jul 24;12:5979-5988. doi: 10.2147/OTT.S198998. eCollection 2019.
4
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology.人工智能在数字病理学中的应用——诊断和精准肿瘤学的新工具。
Nat Rev Clin Oncol. 2019 Nov;16(11):703-715. doi: 10.1038/s41571-019-0252-y. Epub 2019 Aug 9.
5
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer.深度学习可直接从胃肠道癌症的组织学预测微卫星不稳定性。
Nat Med. 2019 Jul;25(7):1054-1056. doi: 10.1038/s41591-019-0462-y. Epub 2019 Jun 3.
6
Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.探索并比较肺腺癌和肺鳞癌之间的基因表达和甲基化差异。
J Cell Physiol. 2019 Apr;234(4):4454-4459. doi: 10.1002/jcp.27240. Epub 2018 Oct 14.
7
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.基于深度学习的非小细胞肺癌组织病理学图像分类和突变预测。
Nat Med. 2018 Oct;24(10):1559-1567. doi: 10.1038/s41591-018-0177-5. Epub 2018 Sep 17.
8
Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer.肿瘤浸润淋巴细胞的空间结构和排列预测早期非小细胞肺癌复发的可能性。
Clin Cancer Res. 2019 Mar 1;25(5):1526-1534. doi: 10.1158/1078-0432.CCR-18-2013. Epub 2018 Sep 10.
9
Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.下调 GSDMD 通过内在的线粒体凋亡途径和抑制 EGFR/Akt 信号转导来抑制肿瘤增殖,并预测非小细胞肺癌的预后良好。
Oncol Rep. 2018 Oct;40(4):1971-1984. doi: 10.3892/or.2018.6634. Epub 2018 Aug 7.
10
Hub genes and key pathways of non-small lung cancer identified using bioinformatics.使用生物信息学鉴定非小细胞肺癌的枢纽基因和关键通路。
Oncol Lett. 2018 Aug;16(2):2344-2354. doi: 10.3892/ol.2018.8882. Epub 2018 Jun 4.